Accord Healthcare, Inc.: Levothyroxine Sodium Tablets, Usp, 100 Mcg (0.1 Mg)

Recall Summary Accord Healthcare is recalling Levothyroxine Sodium Tablets, 100 mcg, distributed nationwide because the tablets contain less active ingredient than specified. The recall affects two bottle sizes: 90-count bottles (NDC 16729-451-15) and 1000-count bottles (NDC 16729-451-17).

Recalling firm

ACCORD HEALTHCARE, INC.

Product

Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-451-15) and b) 1000-count bottles, (NDC 16729-451-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Reason

Subpotent Drug

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-08-06

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

Nationwide within the United States

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/67fa57d2-7d5a-4055-92a1-f8a2f899e86b